• 2017

    • Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.
    • Piramal Realty Marks Exclusive Pre-Launch of Piramal Revanta
    • Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership to Invest in Residential Development in India
    • Piramal Enterprises Limited announces its plan to Enter Housing Finance
  • 2015

    • Piramal Enterprises acquires five brands from Organon India Pvt. Ltd. (OIPL) and MSD BV for its Consumer Products Business
    • Piramal Enterprises acquires the Baby Care Brand – Little’s for the Consumer Products Business
    • Piramal Realty launches a new community for natural and holistic living at Balkum, Thane: Piramal Vaikunth
    • Piramal Realty secures $150 million (INR 900 crore) from Goldman Sachs
    • Warburg Pincus to invest INR 1800cr in Piramal Realty
    • DRG has acquired Healthcare Business Insights (HBI), a trusted provider of best practice research, training and services to more than 1,400 hospitals across the U.S.
    • Piramal Enterprises Ltd. acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.
  • 2013

    • Piramal Enterprises Ltd. consumer products' division acquires the brand CALADRYL® in India.
    • Piramal Water (Sarvajal) honoured with 'Enabling Technology Award of the Year 2013' by Frost & Sullivan.
    • Imaging division's lead radiopharmaceutical, florbetaben, accepted for review by the US FDA and EMA for the visual detection of beta-amyloid in Alzheimer's disease.
  • 2011

    • Piramal's Pharma Solutions manufacturing site at Grangemouth, Scotland becomes the world’s first contract supplier at commercial scale for ADCs.
    • Piramal Realty, the privately owned real estate entity, was formed.
    • Fortune 500 ranks Piramal Healthcare in the top-50 largest corporations across India.
    • Piramal Healthcare acquires Indiareit, a real estate focused investment trust with AUM of USD 760 Million.
    • UN Conference on Trade and Development’s World Investment Report 2011 ranks Piramal Healthcare as No. 5 in the top 10 pharmaceutical contract manufacturers worldwide.
    • Piramal Healthcare acquires 11% of Vodafone India.
    • Piramal Realty acquires Mafatlal Mills in Byculla, Mumbai.
    • Oxygen Bio-research is acquired by Piramal Enterprises and is part of the Pharmaceutical Solutions division.
    • Bharat Serum and Vaccines Ltd – Anesthetics business buyout by Piramal Enterprises Ltd.
  • 2009

    • Minard International Inc. is acquired.
    • RxEliteinc, the U.S. based inhalation anesthetic gas distribution business, is acquired.
  • 2007

    Scientists from Piramal led the first exploration by an Indian pharmaceutical company to develop drug leads from geographies like Antarctica.

  • 2005

    • Piramal Glass acquires a part of The Glass Group (erstwhile Wheaton Glass) in USA.
    • Avecia Pharmaceutical is acquired.
    • Acquired the global inhalation Anaesthetics (IA) business of UK-based RhodiaOrganique Fine Ltd.
    • Forbes 2005 List of ‘Best Small Asian Companies’ ranks Piramal Healthcare as a high value achiever.
  • 2003

    • Global Bulk Drugs is acquired.
    • Sarabhai Piramal is acquired.
  • 2000

    • Started collaborative research with Centre for Biochemical Technology in the field of gene technology.
    • Research alliance established with Hindustan Lever for developing Cosmoceuticals and personal care products.
    • Rhone Poulenc India Limited is acquired.
  • 1998

    • Acquired the research unit of Hoechst Marion Roussel (India) in Mumbai.
    • Nicholas Piramal India Ltd (NPIL) forges joint venture with Boots Healthcare International (BHI) to develop and market consumer healthcare products in India.
  • 1996

    • Entered into a product tie-up with F. Hoffman-La-Roche.
    • Boehringer Mannheim is acquired.
    • The Glass Division successfully commissioned 5 MW captive power plant at Kosamba, Gujarat.
  • 1994

    A joint venture agreement was entered into with Sateliec, France for dental care products.

  • 1992

    • Set up a second formulation plant at Pithampur in Madhya Pradesh with state-of-the-art manufacturing facilities.
    • Nicholas Laboratories Ltd. renamed to Nicholas Piramal India, Ltd.
  • 1990

    Gujarat Glass is merged with the group company, Nicholas Piramal India Ltd.

  • 1984

    Acquired Gujarat Glass.

  • 2016

    • Piramal Fund Management launches an Innovative Flexi Lease Rental Discounting (LRD) for Commercial Assets
    • Piramal Enterprises Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen's injectable anaesthesia and pain management products
    • Piramal Enterprises Limited and Bain Capital Credit to pursue distressed debt investing in India
    • Piramal Enterprises enters into an agreement to acquire Ash Stevens Inc., a US based CDMO for High Potency APIs (HPAPIs)
    • Piramal Realty forays into commercial real estate with launch of Piramal Agastya Corporate Park
    • Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products BusinessPiramal Realty launches its signature project Piramal Aranya at Byculla
    • Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel® to Smith & Nephew
  • 2014

    • Decision Resources Group acquired Relay Technology Management. The acquisition adds new products and significant technological capabilities.
    • Canada Pension Plan Investment Board (CPPIB) and Piramal Enterprises Limited announce a US$ 500 Million Strategic Alliance for Residential Development Debt Financing in India; appoint Piramal Fund Management (at the time known as Indiareit) as advisor.
    • Piramal Enterprises Limited agrees to acquire an effective 20% equity stake in Shriram Capital Limited, a financial services company, for an aggregate consideration of INR 20.14 Billion.
    • Piramal Enterprises Limited acquires 9.99% equity stake in Shriram City Union Finance Limited.
    • APG Asset Management, the Dutch pension fund asset manager and Piramal Enterprises Limited announce a strategic alliance for investing in rupee denominated mezzanine instruments issued by infrastructure companies in India with a target investment of US$ 1 Billion over the next 3 years.
  • 2012

    • Piramal Healthcare Limited is renamed to Piramal Enterprises Limited.
    • Piramal Enterprises Limited acquires Molecular Imaging Development portfolio of Bayer Pharma.
    • Piramal Enterprises acquires health care information management firm, Decision Resources Group, USA for USD 635 Million.
    • Piramal Enterprises starts a non-banking financial company focused on lending to real estate, education and hospitals.
    • BST-CarGel, our innovative bio-orthopedic product for cartilage repair, receives European CE mark approval.
    • Decision Resources Group acquires Abacus International, a UK based global market access solutions company for many of the world’s leading health care companies.
    • Piramal Realty wins the auction of the landmark Hindustan Unilever training center at Worli sea-face, Mumbai.
  • 2010

    • Acquisition of iPill, an oral contraceptive brand, from Cipla.
    • Piramal sells the diagnostics division to Super Religare Laboratories Ltd.
    • Biosyntech, Inc., Canada is acquired by Piramal Enterprises Ltd. This is a part of the Life Sciences vertical, Bio-Orthopedics division.
  • 2008

    • Nicholas Piramal India Limited renamed to Piramal Healthcare Limited.
    • Khandelwal Laboratories is acquired.
    • HLPL-Bangalore is acquired.
  • 2006

    • Piramal Healthcare listed as global leader by S&P Global Challengers.
    • Pfizer's Morpeth UK facility acquired.
  • 2004

    Nicholas forges alliance with scientists from Imperial College of the UK to carry out research in the field of rheumatoid arthritis.

  • 2002

    ICI Pharma is acquired.

  • 1999

    Piramal Glass acquires Ceylon Company Ltd, Sri Lanka.

  • 1997

    NPIL entered into an agreement with Reckitt & Colman for joint marketing of the latter's OTC products in India.

  • 1995

    The bulk drug division of Sumitra Pharmaceutical and Chemicals Ltd. Hyderabad transferred to NPIL.

  • 1993

    Piramal entered into a joint venture agreement with Allergan of U.S.A., the leading manufacturers of Ophthalmic products.

  • 1991

    • A new formulation plant at Pithampur in Madhya Pradesh is commissioned.
    • Glass division activity diversified into the non-pharmaceutical field. New TPD borosilicate plant was implemented at Pithampur.
  • 1988

    Acquired Nicholas Laboratories.

  • 1980

    In the early 1980s, a young Ajay Piramal takes over the reins of the Piramal Group.

This site is best viewed on Internet Explore 8 & above, Google Chrome and Mozilla Firefox
Quick Links